Vertex Pharmaceuticals Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $1.56B | $2.90B | $1.18B |
| FY2017 | $1.50B | $3.55B | $1.67B |
| FY2018 | $1.81B | $3.56B | $2.65B |
| FY2019 | $2.23B | $6.26B | $3.11B |
| FY2020 | $3.07B | $11.75B | $5.99B |
| FY2021 | $3.33B | $13.43B | $6.80B |
| FY2022 | $4.24B | $18.15B | $10.50B |
| FY2023 | $5.15B | $22.73B | $10.37B |
| FY2024 | $6.12B | $22.53B | $4.57B |
| FY2025 | $6.98B | $25.64B | $5.08B |